Back to Results
First PageMeta Content



NOVEN TO ACQUIRE DAYTRANA® METHYLPHENIDATE TRANSDERMAL SYSTEM FROM SHIRE The First and Only Patch for ADHD to be Marketed and Sold by Noven Therapeutics Miami, FL, August 10, Noven Pharmaceuticals, Inc. today an
Add to Reading List

Document Date: 2013-06-27 13:50:54

Open Document

File Size: 143,59 KB

Share Result on Facebook